CA9 and breast carcinoma: Although the studies of breast cancer [5] and our previous studies for cervical cancer [3,4] all revealed that there is no correlation between the expression of CA12 with hypoxia surrogated marker CA9, it is yet to be determined whether the expression of CA12 in cervical cancer is predominantly regulated by a differentiation-related mechanism rather than by tumor hypoxia.